Patent | Date |
---|
Development of agonist epitopes of the human papillomavirus Grant 11,311,613 - Schlom , et al. April 26, 2 | 2022-04-26 |
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use Grant 11,155,588 - Schlom , et al. October 26, 2 | 2021-10-26 |
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use App 20210253656 - Schlom; Jeffrey ;   et al. | 2021-08-19 |
Yeast-MUC1 immunotherapeutic compositions and uses thereof Grant 11,065,318 - Franzusoff , et al. July 20, 2 | 2021-07-20 |
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use App 20200109181 - Schlom; Jeffrey ;   et al. | 2020-04-09 |
Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein Grant 10,508,141 - Schlom , et al. Dec | 2019-12-17 |
Development Of Agonist Epitopes Of The Human Papillomavirus App 20190314479 - Schlom; Jeffrey ;   et al. | 2019-10-17 |
Yeast-muc1 Immunotherapeutic Compositions And Uses Thereof App 20190231859 - Franzusoff; Alex ;   et al. | 2019-08-01 |
Yeast-MUC1 immunotherapeutic compositions and uses thereof Grant 10,188,714 - Franzusoff , et al. Ja | 2019-01-29 |
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use App 20190002513 - Schlom; Jeffrey ;   et al. | 2019-01-03 |
Native and agonist CTL epitopes of the MUC1 tumor antigen Grant 10,138,271 - Schlom , et al. Nov | 2018-11-27 |
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use Grant 10,035,832 - Schlom , et al. July 31, 2 | 2018-07-31 |
Yeast-muc1 Immunotherapeutic Compositions And Uses Thereof App 20170224794 - Franzusoff; Alex ;   et al. | 2017-08-10 |
Yeast-MUC1 immunotherapeutic compositions and uses thereof Grant 9,533,031 - Franzusoff , et al. January 3, 2 | 2017-01-03 |
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use App 20160251406 - SCHLOM; Jeffrey ;   et al. | 2016-09-01 |
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 Grant 9,370,559 - Schlom , et al. June 21, 2 | 2016-06-21 |
Immunogenic peptides and methods of use Grant 9,175,057 - Schlom , et al. November 3, 2 | 2015-11-03 |
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 Grant 8,957,192 - Schlom , et al. February 17, 2 | 2015-02-17 |
System for treating and preventing breast cancer Grant 8,933,041 - Panicali , et al. January 13, 2 | 2015-01-13 |
Native And Agonist Ctl Epitopes Of The Muc1 Tumor Antigen App 20140363495 - Schlom; Jeffrey ;   et al. | 2014-12-11 |
Custom vectors for treating and preventing pancreatic cancer Grant 8,901,093 - Panicali , et al. December 2, 2 | 2014-12-02 |
Immunogenic Epitopes Of Ngep Antigen App 20140287029 - Schlom; Jeffrey ;   et al. | 2014-09-25 |
Immunogenic epitopes of NGEP antigen Grant 8,748,390 - Schlom , et al. June 10, 2 | 2014-06-10 |
Brachyury Polypeptides And Methods For Use App 20140135488 - Schlom; Jeffrey ;   et al. | 2014-05-15 |
Brachyury polypeptides and methods for use Grant 8,613,933 - Schlom , et al. December 24, 2 | 2013-12-24 |
Yeast-muc1 Immunotherapeutic Compositions And Uses Thereof App 20130315941 - Franzusoff; Alex ;   et al. | 2013-11-28 |
Human Cytotoxic T-lymphocyte Epitope And Its Agonist Epitope From The Non-variable Number Of Tandem Repeat Sequence Of Muc-1 App 20130309260 - Schlom; Jeffrey ;   et al. | 2013-11-21 |
Brachyury Polypeptides And Methods For Use App 20120230948 - Schlom; Jeffrey ;   et al. | 2012-09-13 |
Brachyury polypeptides and methods for use Grant 8,188,214 - Schlom , et al. May 29, 2 | 2012-05-29 |
Methods of stimulating an immune response against prostate specific antigen Grant 8,178,508 - Schlom , et al. May 15, 2 | 2012-05-15 |
Immunogenic Epitopes Of Ngep Antigen App 20120052116 - Schlom; Jeffrey ;   et al. | 2012-03-01 |
Human Cytotoxic T-lymphocyte Epitope And Its Agonist Epitope From The Non-variable Number Of Tandem Repeat Sequence Of Muc-1 App 20110319869 - Schlom; Jeffrey ;   et al. | 2011-12-29 |
Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1 Grant 7,999,071 - Schlom , et al. August 16, 2 | 2011-08-16 |
Immunogenic Peptides And Methods Of Use App 20110165117 - Schlom; Jeffrey ;   et al. | 2011-07-07 |
Methods Of Stimulating An Immune Response Against Prostate Specific Antigen App 20110091498 - Schlom; Jeffrey ;   et al. | 2011-04-21 |
Immunogenic peptides and methods of use Grant 7,910,692 - Schlom , et al. March 22, 2 | 2011-03-22 |
Methods of stimulating an immune response against prostate specific antigen Grant 7,871,986 - Schlom , et al. January 18, 2 | 2011-01-18 |
Methods Of Stimulating An Immune Response Against Prostate Specific Antigen App 20090263425 - Schlom; Jeffrey ;   et al. | 2009-10-22 |
Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides Grant 7,547,773 - Schlom , et al. June 16, 2 | 2009-06-16 |
Immunogenic Peptides And Methods Of Use App 20090035266 - Schlom; Jeffrey ;   et al. | 2009-02-05 |
Custom Vectors for Treating and Preventing Pancreatic Cancer App 20080166367 - Panicali; Dennis L. ;   et al. | 2008-07-10 |
Human Cytotoxic T-Lymphoctye Epitope and Its Agonist Eptiope From the Non-Variable Number of Tandem Repeat Sequence of Muc-1 App 20080063653 - Schlom; Jeffrey ;   et al. | 2008-03-13 |
Peptide agonists of prostate-specific antigen and uses therefor Grant 7,247,615 - Schlom , et al. July 24, 2 | 2007-07-24 |
System for treating and preventing breast cancer App 20070110718 - Panicali; Dennis L. ;   et al. | 2007-05-17 |
Prostate specific antigen oligo-epitope peptide App 20070098691 - Schlom; Jeffrey ;   et al. | 2007-05-03 |
Prostate specific antigen oligo-epitope peptide Grant 6,946,133 - Schlom , et al. September 20, 2 | 2005-09-20 |
Prostate specific antigen oligoepitope peptide App 20050196806 - Schlom, Jeffrey ;   et al. | 2005-09-08 |
Peptide agonists of prostate-specific antigen and uses therefor App 20050054575 - Schlom, Jeffrey ;   et al. | 2005-03-10 |